Amgen Hit with Cybersecurity Breach, Patient Data Compromised

Pharmaceutical company Amgen has disclosed a cybersecurity breach that compromised patient data and sensitive company information. The breach, which was reported in an SEC filing, occurred when unauthorized activity was detected in cloud storage hosted by third-party service providers.

The affected data includes proprietary information, patient protected health information, and other sensitive details. While the hack is deemed 'material' due to the volume of files impacted, Amgen notes that it has yet to have any discernible impact on its ability to meet patient needs or financial reporting.

Amgen emphasizes its commitment to safeguarding patient data, stating that an investigation into the breach is ongoing. The company will make necessary regulatory and legal notifications as required.